Terence Rugg

Terence Anthony Rugg currently works at Sonnet BioTherapeutics, Inc., as Chief Medical Officer from 2018.
Dr. Rugg also formerly worked at Genentech, Inc., as Vice President-BioOncology Medical Affairs from 2009 to 2014, Aventis, Inc., as Head-Oncology & Global Medical Affairs from 2002 to 2004, SGX Pharmaceuticals, Inc., as Chief Medical Officer & VP-Development from 2006 to 2008, Sanofi-Aventis U.S.
LLC, as Vice President from 2004 to 2006, Sanofi US Services, Inc., as Vice President & Head-US Oncology/Medical Affairs from 2004 to 2006, and Sonnet BioTherapeutics Holdings, Inc., as Chief Medical Officer.
Dr. Rugg received his graduate degree from the University of KwaZulu-Natal and doctorate degree from the University of Zimbabwe.